About Us
About Us
Group Introduction Management Team Development Strategy Corporate Culture Milestones Contact Us
News
News
News
Global
Global
Global Layout Asia North America Africa Europe
Products
Products
API Preparation
R&D and Innovation
R&D and Innovation
Overview R&D Centers Development Progress Technology Platform Introduction To Key Projects
Partnership
Partnership
We Seek We Offer
Investor Relations
Investor Relations
Corporate Governance Financial Highlight Periodical Ad-hoc Investor Interaction

En

English 中文
  • About Us
    Group Introduction Management Team Development Strategy Corporate Culture Milestones Contact Us
  • News
    News
  • Global
    Global Layout Asia North America Africa Europe
  • Products
    API Preparation
  • R&D and Innovation
    Overview R&D Centers Development Progress Technology Platform Introduction To Key Projects
  • Partnership
    We Seek We Offer
  • Investor Relations
    Corporate Governance Financial Highlight Periodical Ad-hoc Investor Interaction
Products
CURRENT LOCATION: HOME > Preparation > Steroid Hormone Products

API

Preparation

Steroid Hormone Products

Natural Plant-based Medicine

Central Nervous System Drugs

Animal Medicine

Featured products

Narcotic

Steroid Hormone Products
Name PREPARATION USAGE AND INDICATION
Mifepristone Tablets SFDA approval number H20033551 Mifepristone Tablets are used in sequential combination with prostaglandin drugs to terminate a pregnancy within 49 days gestation.
Misoprostol Tablets SFDA approval number H20073696 This drug is used in sequential combination with Mifepristone Tablets to terminate an early pregnancy within 49 days gestation.
Compound Mifepristone Tablets SFDA approval number H20040365 This drug is used in sequential combination with Misoprostol Tablets to terminate an early pregnancy within 49 days gestation.
Levonorgestrel Capsules SFDA approval number H20080243 This product is used for female emergency contraception, that is, when unprotected sex occurs or other contraceptive methods accidentally fail.
Mifepristone Tablets SFDA approval number H20083780 This product is used for the treatment of uterine myomas and is a national essential drug. This product is a strong antagonist of progesterone. It can significantly shrink myomas, and quickly improve anemia. This product is used for preoperative treatment of adult women at childbearing age who have moderate to severe symptoms due to uterine myomas; The course of treatment lasts for 3 months.
Cyproterone Acetate Tablets SFDA approval number H20056637 This product is an androgen receptor inhibitor and a national essential drug. This product is used for the treatment of hypersexuality and prostate cancer in males. This product is used for the treatment of acne, seborrheic dermatitis and hirsutism in females.
ANAESTHETIC
Humanwell is the largest supplier of analgesics (post-operative) in China and has the most comprehensive anesthesia product portfolio in the world. With more than 4,000 sales professionals, the largest holding subsidiary Yichang Humanwell promotes its product portfolio in all major hospitals in China and holds more than 60% of the analgesics market share. Humanwell actively develops overseas markets. Its products have been registered and sold in 50 countries and regions, and 17 high-end sustained-release drugs have been approved by the US FDA.

CURRENT LOCATION:

HOME > Preparation> Steroid Hormone Products
About Us
Group Introduction
Management Team
Development Strategy
Corporate Culture
Milestones
Contact Us
News
News
Global
Global Layout
Asia
North America
Africa
Europe
Products
API
Preparation
R&D and Innovation
Overview
R&D Centers
Development Progress
Technology Platform
Introduction To Key Projects
Partnership
We Seek
We Offer
Investor Relations
Corporate Governance
Financial Highlight
Periodical
Ad-hoc
Investor Interaction

COPYRIGHT 2024 HUMANWELL GROUP ALL RIGHTS RESERVED.

Privacy protection Legal statement
Technical Support: Lucky xp
Group Subsidiary GROUP SUBSIDIARY
Yichang Humanwell Pharmaceutical Co., Ltd Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. Wuhan Humanwell Pharmaceutical Co., Ltd Xinjiang Uyghur Pharmaceutical Co., Ltd. Humanwell Puke Pharmaceutical (Wuhan) Co., Ltd Yichang Sanxia Pharmaceutical Co., Ltd Epic Pharma, LLC Beijing Baron Medical Equipment Co., Ltd. Wuhan Tianrun Health Products Co., Ltd.
QRCode
Group Subsidiary GROUP SUBSIDIARY
Yichang Humanwell Pharmaceutical Co., Ltd Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. Wuhan Humanwell Pharmaceutical Co., Ltd Xinjiang Uyghur Pharmaceutical Co., Ltd. Humanwell Puke Pharmaceutical (Wuhan) Co., Ltd Yichang Sanxia Pharmaceutical Co., Ltd Epic Pharma, LLC Beijing Baron Medical Equipment Co., Ltd. Wuhan Tianrun Health Products Co., Ltd.
QRCode

COPYRIGHT 2024 HUMANWELL GROUP ALL RIGHTS RESERVED.

Privacy protection Legal statement
Technical Support: Lucky xp